Skip to main content

News and Events

Stay up to date about
RECOVER

Understanding of PASC (post-acute sequelae of SARS-CoV-2), including Long COVID, is constantly evolving as new research is funded and studies begin. Stay informed by reading the latest news, watching videos, and participating in upcoming events.

Latest News and Updates


RECOVER-NEURO enrolls first participant in trial

RECOVER-NEURO, a clinical trial examining how different interventions can help people with symptoms of cognitive dysfunction related to long COVID, has enrolled its first participant. RECOVER-NEURO is part of the RECOVER initiative, and all RECOVER clinical trials are coordinated by the Duke Clinical Research Institute (DCRI). This Phase 2 trial will focus on possible treatments to improve working memory, attention, executive functions, and information processing speed for people who have Long COVID.

Read the full news release.

Continue Reading
  • recoverCOVID.org
  • September 5, 2023

RECOVER-VITAL enrolls first participant in trial

RECOVER-VITAL, a clinical trial examining if the antiviral PAXLOVID (nirmatrelvir and ritonavir) improves symptoms for people who have long COVID, has enrolled its first participant. RECOVER-VITAL is part of the RECOVER initiative and all RECOVER clinical trials are coordinated by the Duke Clinical Research Institute (DCRI). Researchers believe that viral persistence (when the virus that causes COVID-19 stays in the body and causes damage to organs or the immune system to not function properly) may cause long COVID symptoms.

Read the full news release.

Continue Reading
  • recoverCOVID.org
  • July 31, 2023

NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment

The National Institutes of Health has launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months. Treatments will include drugs, biologics, medical devices, and other therapies. The trials are designed to evaluate multiple treatments simultaneously to identify more swiftly those that are effective. The trials will focus on several of the symptoms described as most burdensome by people experiencing long COVID.

Read the full news release.

Continue Reading
  • recoverCOVID.org
  • July 31, 2023

RECOVER Research Q&A: RECOVER “First Look” Adult Cohort Study

On May 25, 2023, RECOVER shared its “first look” into findings from the adult cohort study. The study, titled “Development of a Definition of Post-Acute Sequelae of SARS-CoV-2 Infection” was peer-reviewed and published in the Journal of the American Medical Association (JAMA). As a result of widespread interest in the study, a Q&A was developed to answer some of the most asked questions about this research and why it matters.

Read the Research Q&A.

Continue Reading
  • recoverCOVID.org
  • June 9, 2023

RECOVER study provides scientists with deeper insight into Long COVID

Study identifies most common Long COVID symptoms with aim of improving future diagnostics and treatment

Initial findings from a RECOVER study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about Long COVID. Researchers found in the study, published in JAMA, that certain Long COVID symptoms occurred together, and defined four symptom patterns or clusters that have a range of impacts on patient health. The research team also found that Long COVID was more common and severe in study participants infected before the 2021 Omicron variant.

Read the full news release.

Continue Reading
  • recoverCOVID.org
  • May 25, 2023

Obstructive sleep apnea associated with increased risks for Long COVID

Study suggests adults with both the sleep disorder and COVID may benefit from clinical monitoring.

Among people who have had COVID-19, adults with obstructive sleep apnea were more likely to experience long-term symptoms suggestive of Long COVID than those without the sleep disorder, according to a large study supported by the National Institutes of Health (NIH). In fact, multiple analyses of electronic health records (EHR) uncovered adults with sleep apnea may have up to a 75% higher risk of developing Long COVID. The findings are published in the journal SLEEP. Read the full news release.

Continue Reading
  • recoverCOVID.org
  • May 11, 2023

NIH Director’s blog: What Clinical Research Comes Next for Helping People with Long COVID

“I connected with RECOVER to be a part of the answers that I was looking for when I was at my worst.” Long COVID patient and RECOVER representative, Nitza Rochez (Bronx, NY)

People, like Nitza Rochez, who are living with Long COVID—the wide-ranging health issues that can follow an infection with SARS-CoV-2, the coronavirus that causes COVID-19—experience disabling symptoms with significant physical, emotional and financial consequences.

The NIH has been engaging and listening to Nitza and others living with Long COVID even before the start of its Researching COVID to Enhance Recovery (RECOVER) Initiative. But now, with the launch of RECOVER, patients and those with affected family or community members have joined researchers, clinicians, and experts in their efforts to unlock the mysteries of Long COVID. All have come together to understand what causes the condition, identify who is most at risk, and determine how to prevent and treat it. Read the full update from Gary Gibbons, M.D., Walter J. Koroshetz, M.D., and Hugh Auchincloss, M.D. at the NIH Director’s Blog.

Continue Reading
  • NIH.gov
  • March 2, 2023

NIH RECOVER research identifies potential long COVID disparities

Black and Hispanic Americans appear to experience more symptoms and health problems related to long COVID, a lay term that captures an array of symptoms and health problems, than white people, but are not as likely to be diagnosed with the condition, according to new research funded by the National Institutes of Health. The findings – from two different studies by NIH’s Researching COVID to Enhance Recovery (RECOVER) Initiative – add to a growing body of research aimed to better understand the complex symptoms and other issues associated with long COVID that millions have experienced. Read the full news release.

Continue Reading
  • NIH.gov
  • February 16, 2023

Duke Selected as RECOVER Clinical Trials Data Coordinating Center

The Duke Clinical Research Institute (DCRI) has been named the Clinical Trials Data Coordinating Center (DCC) for the NIH RECOVER Initiative. DCRI will partner with the RECOVER Administrative Coordinating Center (ACC), based at RTI International.

Together, the ACC and DCC will oversee the study’s clinical trial infrastructure, establish a patient registry, simultaneously launch prevention and therapeutic multi-intervention studies for both adults and children, and work to accelerate the clinical trial process.

The DCC will align with other, existing COVID research projects, including the RECOVER Consortium and the NIH-funded ACTIV (Accelerating COVID-19 Therapeutic Interventions and Vaccines) studies, to help advance the science on the health effects of COVID.

Continue Reading
  • DCRI.org
  • August 2, 2022

RECOVER Research Awards

RECOVER has awarded over $37 million in funding for more than 40 research projects. These studies will quickly advance what we know about how COVID affects different body tissues and organs.

The studies will tell us more about how the many different symptoms develop in people who have had COVID. We’ll also learn about what causes the long-term effects of COVID, known as Long COVID.

The research awards include:

  • More funding to researchers whose current studies show promise to quickly advance understanding of what causes lasting symptoms in Long COVID.
  • New funding to teams of RECOVER researchers from different specialty areas to support further analysis of tissue samples and data collected in current RECOVER studies.

View the awardees

Continue Reading
  • recoverCOVID.org
  • August 12, 2022

Videos and Presentations


RECOVER Research Review (R3) SEMINAR SERIES on a background showing the RECOVER COVID virus icon

The goal of the R3 Seminar Series is to catalyze a shared understanding of the research of the scientific stakeholder community within the RECOVER consortium. Working and learning together, while keeping each other up to date on the latest insights to accelerate discovery. Some R3 sessions will also inform the public about RECOVER and other research on PASC. All sessions will be recorded and posted to recoverCOVID.org.

Visit the R3 Seminar Page to View Upcoming Seminars
  • NIH
  • Ongoing series began March 1, 2022

NIH VideoCast Recording: Highlights of Pandemic Related Successes in Tribal Communities Webinar

NIH RECOVER, the Community Engagement Alliance (CEAL), and the Tribal Health Research Office (THRO) co-sponsored the Highlights of Pandemic Related Successes in Tribal Communities Webinar, held on Wednesday, December 7, 2022. This event was tailored specifically for research team members across RECOVER, CEAL, and NIH to spotlight successful approaches used during the COVID-19 pandemic to engage members of Tribal Communities. Experts from the Center for Indigenous Health and the Indian Health Service shared how they met the needs and priorities of these communities, overcame barriers to vaccination, and developed best practices for engagement around COVID-19 related research that might be applicable to other research efforts and public health matters of importance. The webinar also featured a panel discussion and a live Q&A session, which were moderated by Mose A Herne, MPH, MS, THRO Senior Advisor.

View the recording.

Continue Reading
  • NIH
  • December 7, 2022

RECOVER Electronic Health Records (EHR) Study Compares Risks of Heart Problems after COVID Infection and mRNA COVID Vaccination

Researchers from RECOVER and the National Patient-Centered Clinical Research Network (PCORnet) compared the risk of heart problems after COVID infection and after mRNA COVID vaccination. They used EHR data from 40 health care systems representing more than 15 million people, aged 5 years or older. The study compared people of similar age, gender, and number of vaccine doses to see what increased the risk of heart problems.

The study found that the risk of heart problems after getting an mRNA COVID vaccine was very low for people of all ages and genders. Also, the risk of having heart problems after having COVID was significantly higher than after getting an mRNA COVID vaccine.

These findings support the continued use of the recommended mRNA COVID-19 vaccine for all eligible people aged 5 or older. See this recent study in the CDC’s Morbidity and Mortality Weekly Report (MMWR).

Continue Reading
  • NIH
  • April 1, 2022

RECOVER January Listening Session Recording Available: Understanding Long COVID Across Communities of Color (January 21, 2022)

This event facilitated discussion between RECOVER researchers and members of organizations that represent and support communities of color to better understand levels of awareness of Long COVID in these communities. It also informed opportunities to promote diverse and inclusive participation in the RECOVER Initiative studies. Dr. Andrea Lerner from the NIH and Dr. Natasha Williams from NYU Langone Health cohosted the event alongside the moderator, Dr. James E.K. Hildreth of Meharry Medical College.

View the recording.

A transcript of the event is available here (PDF, 136 KB).

Continue Reading
  • NIH
  • January 21, 2022

PASC Seminar Series Sponsored by the Foundation for the National Institutes of Health

The Foundation for the National Institutes of Health sponsors the ACTIV seminar series, which is organized in partnership with Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) and the National Heart, Lung, and Blood Institute. ACTIV brings together leading experts on PASC to share their published or ongoing research on different aspects of the disease. The sessions are recorded and published, and you can watch past sessions at the ACTIV link above. Some past ACTIV presentations include:

  • Barriers to Improving PASC Outcomes – Dr. Michelle Gong, MD, MS, Albert Einstein College of Medicine, October 4, 2021
  • Probing Disease Mechanisms of Long COVID – Dr. Akiko Iwasaki, PhD, Yale University School of Medicine, October 28, 2021
  • Neurological Symptoms During and After COVID-19 – Dr. Shelli Farhadian, MD, PhD, Yale University School of Medicine, November 4, 2021
  • Observations on Long COVID through an ME/CFS Lens – Peter Rowe, MD, Johns Hopkins Medicine, January 14, 2022
Continue Reading
  • Foundation for the National Institutes of Health
  • Ongoing series began October 4, 2021

RECOVER Launches the Live Series: First Session Recording

The first RECOVER Live Series event, Inside the RECOVER Initiative, a Conversation with Dr. Stuart Katz of NYU Langone Health, was held on November 30, 2021. Dr. Katz shared information from experts working on the RECOVER Initiative about what is being done to understand, prevent, and treat PASC, including Long COVID. This event also included a live Q&A session, where people viewing online posted questions for Dr. Katz. View the recording.

A transcript of the event is available here (PDF, 106 KB).

  • NIH.gov
  • November 30, 2021

Understanding Long COVID: The Unseen Public Health Crisis

Understanding Long COVID: The Unseen Public Health Crisis

Harvard T.H. Chan School of Public Health hosted a free, online discussion on November 19, 2021 that brought together clinicians, researchers, policy experts, and Long COVID patients.

  • Harvard T.H. School of Public Health
  • November 19, 2021

RECOVER Initiative Stakeholder Briefing

RECOVER Initiative Stakeholder Briefing

In coordination with the RECOVER Initiative announcement on September 15, 2021, the NIH invited RECOVER Initiative stakeholders to join NIH leadership in a public briefing to discuss the announcement and address questions from the community. The briefing was led by Dr. Amy Patterson (NIH – NHLBI), with Dr. Stuart Katz (NYU, Principal Investigator of the RECOVER Clinical Science Core), Emily Taylor (Solve M.E.), and Dr. Lenora Johnson (NIH – NHLBI), who addressed more than 550 virtual attendees and answered questions about the RECOVER Initiative.

A transcript of the event is available here (PDF, 137 KB).

  • NIH.gov
  • September 15, 2021

Long-term COVID Patient Engagement: Best Practices Informed By Patients' Experiences Seeking Medical Care

Long-term COVID Patient Engagement: Best Practices Informed By Patients' Experiences Seeking Medical Care

During COVID-19 Grand Rounds hosted by the NIH Health Care Systems Research Collaboratory on July 23, 2021, representatives of Survivor Corps presented their efforts to conduct research with their online community of 170,000 individuals affected by COVID-19. Survivor Corps is a grassroots movement using its members' collective experience to build a repository of data sets and research tools to support COVID-19 research, including studies on PASC and Long COVID.

  • NIH Collaboratory
  • July 23, 2021

Neurologic and Psychiatric Effects of SARS-CoV-2 Infection

Neurologic and Psychiatric Effects of SARS-CoV-2 Infection

Hosted by the NIH, this meeting looked at the long-term effects of SARS-CoV-2 infection on the brain and possible interactions with other infections, such as HIV. Watch the recording to hear scientists discuss related research gaps and priorities.

  • NIH.gov
  • July 14-15, 2021

Treating Long COVID: Clinician Experience with Post-Acute COVID-19 Care

Treating Long COVID: Clinician Experience with Post-Acute COVID-19 Care

In this webinar, clinicians share their experiences with treating Long COVID and establishing clinics that provide care for patients with the long-term effects of SARS-CoV-2 infection.

  • CDC.gov
  • February 1, 2021

Media Inquiries

Are you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in the subject line.

Back to Top